EP 2675446 A1 20131225 - OMEGA 3 FORMULATIONS COMPRISING EPA, DHA AND DPA FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE
Title (en)
OMEGA 3 FORMULATIONS COMPRISING EPA, DHA AND DPA FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE
Title (de)
OMEGA-3-FORMULIERUNGEN MIT EPA, DHA UND DPA ZUR BEHANDLUNG VON RISIKOFAKTOREN FÜR KARDIOVASKULÄRE ERKRANKUNGEN
Title (fr)
PRÉPARATIONS À BASE D'OMÉGA-3 COMPRENANT EPA, DHA ET DPA POUR LE TRAITEMENT DES FACTEURS DE RISQUE DANS LA MALADIE CARDIOVASCULAIRE
Publication
Application
Priority
- US 201161457271 P 20110216
- US 2012025021 W 20120214
Abstract (en)
[origin: WO2012112527A1] A formulation for treating omega-3 fatty acid deficiency is disclosed containing about 90% or more omega 3 fatty acids by weight comprised of a combination of Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and Docosahexaenoic acid (DHA) in a weight ratio of EPA: DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA comprise about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition. EPA + DHA are about 80%» of the total formulation and about 89% of the total omega 3 fatty acid content of the composition. The formulation may further contain specific amounts of arachidonic acid (AA) and of omega-3 fatty acids having 18 carbon atoms, including one or more of stearidonic acid (SDA) and alpha-linolenic acid (ALA).
IPC 8 full level
A61K 31/202 (2006.01); A61K 45/06 (2006.01); A61P 9/00 (2006.01)
CPC (source: EP)
A61K 31/202 (2013.01); A61P 9/00 (2017.12); A61P 9/08 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2012112527A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012112527 A1 20120823; CA 2827579 A1 20120823; EP 2675446 A1 20131225; JP 2014505731 A 20140306
DOCDB simple family (application)
US 2012025021 W 20120214; CA 2827579 A 20120214; EP 12707420 A 20120214; JP 2013554542 A 20120214